| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |